Logo-bi
Review

Cancer treatment comes to age: from one-size-fits-all to next-generation sequencing (NGS) technologies
Sepideh Parvizpour* ORCID, Hanieh Beyrampour-Basmenj, Jafar Razmara* ORCID, Farhad Farhadi, Mohd Shahir Shamsir
Bioimpacts. 2024;14(4): 29957. doi: 10.34172/bi.2023.29957
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy Scopus 0
CitedBy PMC 0
CitedBy CrossRef 0
Graphical Abstract
Review

Unveiling the biological effects of radio-frequency and extremely-low frequency electromagnetic fields on the central nervous system performance
Ramin Eskandani ORCID, Mohammad Ismail Zibaii* ORCID
Bioimpacts. 2024;14(4): 30064. doi: 10.34172/bi.2023.30064
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy Scopus 0
CitedBy PMC 0
CitedBy CrossRef 0
Graphical Abstract
Original Article

Design and implementation of a lab-on-a-chip for assisted reproductive technologies
Firooz Safaefar ORCID, Javad Karamdel* ORCID, Hadi Veladi* ORCID, Masoud Maleki ORCID
Bioimpacts. 2024;14(4): 28902. doi: 10.34172/bi.2023.28902
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy Scopus 0
CitedBy PMC 0
CitedBy CrossRef 0
Graphical Abstract
Original Article

Thiazolo-pyridopyrimidines: An in silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines
Chaithra R Shetty ORCID, C. S. Shastry* ORCID, Parasuraman P, Srinivas Hebbar
Bioimpacts. 2024;14(4): 29951. doi: 10.34172/bi.2023.29951
Article logoArticle
PDFPDF
Supplementary 1Suppl 1
Supplementary 2Suppl 2
XMLXML
Cited By:
CitedBy Scopus 0
CitedBy PMC 0
CitedBy CrossRef 0
Graphical Abstract
Original Article

Integrating rapamycin with novel PI3K/Akt/mTOR inhibitor microRNAs on NOTCH1-driven T-cell acute lymphoblastic leukemia (T-ALL)

Fateme Arjmand ORCID, Samaneh Shojaei, Mitra Khalili, Hossein Dinmohammadi, Behzad Poopak, Samira Mohammadi-Yeganeh* ORCID, Yousef Mortazavi* ORCID
Bioimpacts. 2024;14(4): 28870. doi: 10.34172/bi.2023.28870
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy Scopus 0
CitedBy PMC 0
CitedBy CrossRef 0
Graphical Abstract
Original Article

New approach to generating of human monoclonal antibodies specific to the proteolytic domain of botulinum neurotoxin A
Marina Vladimirovna Silkina ORCID, Alena Sergeevna Kartseva ORCID, Alena Konstantinovna Riabko ORCID, Mariia Aleksandrovna Makarova ORCID, Metkhun Madibronovich Rogozin, Yana Olegovna Romanenko ORCID, Igor Georgievich Shemyakin ORCID, Ivan Alekseevich Dyatlov ORCID, Victoria Valerievna Firstova* ORCID
Bioimpacts. 2024;14(4): 27680. doi: 10.34172/bi.2023.27680
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy Scopus 0
CitedBy PMC 0
CitedBy CrossRef 0
Graphical Abstract
Original Article

Telomerase and mitochondria inhibition promote apoptosis and TET2 and ANMT3a expression in triple negative breast cancer cell lines
Zeinab Mazloumi ORCID, Ali Rafat, Khadijeh Dizaji Asl, Mohammad Karimipour, Dariush Shanehbandi, Mehdi Talebi, Majid Montazer, Ali Akbar Movassaghpour, Alireza Dehnad, Raheleh Farahzadi, Hojjatollah Nozad Charoudeh* ORCID
Bioimpacts. 2024;14(4): 27640. doi: 10.34172/bi.2023.27640
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy Scopus 0
CitedBy PMC 0
CitedBy CrossRef 0
Graphical Abstract
Original Article

Interaction of toll-like receptors and ACE-2 with different variants of SARS-CoV-2: A computational analysis
Azadeh Zahmatkesh* ORCID, Elham Salmasi, Reza Gholizadeh
Bioimpacts. 2024;14(4): 30150. doi: 10.34172/bi.2024.30150
Article logoArticle
PDFPDF
XMLXML
Cited By:
CitedBy Scopus 0
CitedBy PMC 0
CitedBy CrossRef 0
Graphical Abstract

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge